栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/06 | 2,011 | 2,019 | 1,994 | 2,007 | +1 | ±0% | 65,300 |
| 2024/06/05 | 1,995 | 2,016 | 1,991 | 2,006 | +6 | +0.3% | 64,300 |
| 2024/06/04 | 2,031 | 2,063 | 2,000 | 2,000 | -81 | -3.9% | 169,400 |
| 2024/06/03 | 2,100 | 2,104 | 2,080 | 2,081 | -16 | -0.8% | 54,100 |
| 2024/05/31 | 2,052 | 2,097 | 2,052 | 2,097 | +27 | +1.3% | 280,400 |
| 2024/05/30 | 2,042 | 2,074 | 2,022 | 2,070 | +9 | +0.4% | 150,700 |
| 2024/05/29 | 2,033 | 2,068 | 2,020 | 2,061 | -10 | -0.5% | 91,800 |
| 2024/05/28 | 2,084 | 2,089 | 2,056 | 2,071 | -11 | -0.5% | 70,900 |
| 2024/05/27 | 2,036 | 2,085 | 2,003 | 2,082 | +44 | +2.2% | 75,200 |
| 2024/05/24 | 2,030 | 2,049 | 2,022 | 2,038 | -19 | -0.9% | 81,500 |
| 2024/05/23 | 2,044 | 2,079 | 2,038 | 2,057 | -15 | -0.7% | 75,300 |
| 2024/05/22 | 2,080 | 2,089 | 2,051 | 2,072 | -28 | -1.3% | 114,800 |
| 2024/05/21 | 2,146 | 2,170 | 2,100 | 2,100 | -46 | -2.1% | 88,800 |
| 2024/05/20 | 2,136 | 2,176 | 2,107 | 2,146 | -1 | ±0% | 109,500 |
| 2024/05/17 | 2,120 | 2,153 | 2,094 | 2,147 | +30 | +1.4% | 109,600 |
| 2024/05/16 | 2,109 | 2,130 | 2,082 | 2,117 | +14 | +0.7% | 140,100 |
| 2024/05/15 | 2,150 | 2,160 | 2,092 | 2,103 | -67 | -3.1% | 160,700 |
| 2024/05/14 | 2,212 | 2,212 | 2,148 | 2,170 | +97 | +4.7% | 288,300 |
| 2024/05/13 | 2,041 | 2,076 | 2,009 | 2,073 | +32 | +1.6% | 143,700 |
| 2024/05/10 | 2,051 | 2,103 | 2,017 | 2,041 | +57 | +2.9% | 193,800 |
| 2024/05/09 | 2,004 | 2,018 | 1,973 | 1,984 | -20 | -1% | 101,900 |
| 2024/05/08 | 2,034 | 2,042 | 1,996 | 2,004 | -26 | -1.3% | 72,900 |
| 2024/05/07 | 2,030 | 2,041 | 2,015 | 2,030 | +3 | +0.1% | 58,200 |
| 2024/05/02 | 2,011 | 2,027 | 2,001 | 2,027 | +24 | +1.2% | 32,200 |
| 2024/05/01 | 2,000 | 2,010 | 1,977 | 2,003 | -2 | -0.1% | 58,500 |
| 2024/04/30 | 2,008 | 2,012 | 1,983 | 2,005 | -2 | -0.1% | 70,200 |
| 2024/04/26 | 2,003 | 2,023 | 1,988 | 2,007 | -18 | -0.9% | 94,400 |
| 2024/04/25 | 2,022 | 2,037 | 2,004 | 2,025 | +20 | +1% | 147,600 |
| 2024/04/24 | 2,000 | 2,015 | 1,997 | 2,005 | -1 | ±0% | 45,500 |
| 2024/04/23 | 2,000 | 2,016 | 1,979 | 2,006 | +47 | +2.4% | 116,900 |
| 2024/04/22 | 1,952 | 1,968 | 1,947 | 1,959 | +24 | +1.2% | 53,200 |
| 2024/04/19 | 1,951 | 1,964 | 1,908 | 1,935 | -35 | -1.8% | 130,500 |
| 2024/04/18 | 1,955 | 1,975 | 1,945 | 1,970 | +15 | +0.8% | 79,500 |
| 2024/04/17 | 2,000 | 2,003 | 1,945 | 1,955 | -41 | -2.1% | 118,900 |
| 2024/04/16 | 1,965 | 2,008 | 1,950 | 1,996 | -4 | -0.2% | 94,500 |
| 2024/04/15 | 1,985 | 2,009 | 1,976 | 2,000 | +1 | +0.1% | 72,400 |
| 2024/04/12 | 2,034 | 2,049 | 1,999 | 1,999 | -23 | -1.1% | 129,400 |
| 2024/04/11 | 2,001 | 2,034 | 1,999 | 2,022 | +1 | ±0% | 94,400 |
| 2024/04/10 | 2,008 | 2,036 | 2,005 | 2,021 | +14 | +0.7% | 98,900 |
| 2024/04/09 | 1,998 | 2,015 | 1,996 | 2,007 | +10 | +0.5% | 73,400 |
| 2024/04/08 | 1,970 | 2,008 | 1,970 | 1,997 | +37 | +1.9% | 157,100 |
| 2024/04/05 | 1,956 | 1,977 | 1,931 | 1,960 | +10 | +0.5% | 152,200 |
| 2024/04/04 | 1,962 | 1,971 | 1,942 | 1,950 | -1 | -0.1% | 124,900 |
| 2024/04/03 | 1,973 | 1,981 | 1,941 | 1,951 | -29 | -1.5% | 189,900 |
| 2024/04/02 | 1,983 | 1,983 | 1,972 | 1,980 | -4 | -0.2% | 79,700 |
| 2024/04/01 | 2,012 | 2,012 | 1,957 | 1,984 | -16 | -0.8% | 89,500 |
| 2024/03/29 | 1,954 | 2,006 | 1,954 | 2,000 | +35 | +1.8% | 71,000 |
| 2024/03/28 | 1,990 | 2,011 | 1,954 | 1,965 | -48 | -2.4% | 257,000 |
| 2024/03/27 | 2,022 | 2,026 | 1,997 | 2,013 | +42 | +2.1% | 170,000 |
| 2024/03/26 | 1,948 | 1,978 | 1,948 | 1,971 | +13 | +0.7% | 86,900 |
301～
350
件表示中 / 7025件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 249,200円 | +4.1% | -3.1% | 2.33% | 21.65倍 | 1.89倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 持田薬 | 313,500円 | +5.1% | -7.0% | 2.55% | 20.58倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 204,000円 | +3.1% | -6.5% | 2.35% | 9.47倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 151,900円 | -2.4% | -52.3% | 3.75% | 18.18倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 90,900円 | +20.3% | - | 0.00% | 161.17倍 | 1.24倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
